VC
Vivo Capital’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-198,983
| Closed | -$5.59M | – | 50 |
|
|
2022
Q3 | $5.59M | Sell |
198,983
-359,653
| -64% | -$10.1M | 0.62% | 37 |
|
|
2022
Q2 | $15.1M | Sell |
558,636
-69,720
| -11% | -$1.88M | 1.51% | 15 |
|
|
2022
Q1 | $21.4M | Buy |
628,356
+143,903
| +30% | +$4.9M | 1.47% | 14 |
|
|
2021
Q4 | $18.7M | Hold |
484,453
| – | – | 1.13% | 23 |
|
|
2021
Q3 | $26.2M | Sell |
484,453
-484,453
| -50% | -$26.2M | 1.17% | 21 |
|
|
2021
Q2 | $32.4M | Sell |
968,906
-322,969
| -25% | -$10.8M | 1.4% | 20 |
|
|
2021
Q1 | $26.6M | Hold |
1,291,875
| – | – | 0.94% | 22 |
|
|
2020
Q4 | $22.6M | Sell |
1,291,875
-430,625
| -25% | -$7.54M | 1.01% | 22 |
|
|
2020
Q3 | $25.5M | Buy |
1,722,500
+122,500
| +8% | +$1.82M | 1.48% | 16 |
|
|
2020
Q2 | $20.8M | Buy |
+1,600,000
| New | +$20.8M | 1.49% | 17 |
|